Recent Articles from Stocktwits
StockTwits, founded in 2008 by Howard Lindzon and Soren Macbeth, is a leading social media platform designed specifically for investors and traders to share real-time market insights, ideas, and strategies. Headquartered in New York City, the company pioneered the use of "cashtags" (e.g., $AAPL) to organize financial discussions, initially integrating with Twitter before evolving into a standalone network.
Website: https://www.stocktwits.com
The company said that no reduction in depressive symptoms were observed in the BHV-7000 trial over six weeks as compared with placebo.
Via Stocktwits · December 24, 2025
The stocks were tracked during the shortened Christmas Eve session across healthcare, consumer, and banking.
Via Stocktwits · December 24, 2025
Musk was responding to a media report which proposed that SpaceX could go public via a merger with telecommunications company Echostar instead of pursuing a conventional initial public offering.
Via Stocktwits · December 24, 2025
Amazon, Roblox, Visa, Mastercard Rise After Goldman Calls ‘Fallen Angels’ the Next Tech Comeback Playstocktwits.com
Via Stocktwits · December 24, 2025
Wall Street Turns Jolly Heading Into Christmas: S&P 500 Notches New Record As Santa Claus Rally Beginsstocktwits.com
Via Stocktwits · December 24, 2025
Bitcoin’s $90K Test: Retail Is Divided Whether A Year-End Bounce Is Still Possiblestocktwits.com
Via Stocktwits · December 24, 2025
SRx Health Hits Record Low After Eric Jackson Takes Over Crypto Push — Former Peter Lynch Associate Calls It A ‘Sinking Ship’stocktwits.com
Via Stocktwits · December 23, 2025
Citi has captured investors' attention after a relentless rally that has delivered gains in 21 of the past 23 sessions.
Via Stocktwits · December 24, 2025
The stock hit a record high on Wednesday, helped by positive commentary from top analysts and strong revenue expectations for the current quarter.
Via Stocktwits · December 24, 2025
The investigational drug EDG-7500 was generally well tolerated in the trial, the company said.
Via Stocktwits · December 24, 2025
Shares traded lower as investors weighed autonomous driving updates against ongoing regulatory review.
Via Stocktwits · December 24, 2025
Bernie Sanders Targets Walgreens Owner As Workers Lose Holiday Pay — Demands Answers On Layoffs And Executive Paystocktwits.com
Via Stocktwits · December 23, 2025
Pentagon Blames Lockheed Martin For F-35’s Lack Of Availabilitystocktwits.com
Via Stocktwits · December 23, 2025
Trump Says Anyone Who Disagrees With Him ‘Will Never Be The Fed Chairman’ As Rate Fears Kill Ralliesstocktwits.com
Via Stocktwits · December 23, 2025
Novo Nordisk, Trinity Biotech, Starfighters Space, VisionWave, ServiceNow: Stocks Making The Biggest Moves Todaystocktwits.com
Via Stocktwits · December 23, 2025
Precious metal mining stocks, including Hycroft Mining and Fortuna Silver Mines, slid lower on Wednesday after gold and silver pared gains from their record rallies.
Via Stocktwits · December 24, 2025
While Trump administration officials continue to back lower rates, market expectations point to the Fed taking a pause next month.
Via Stocktwits · December 24, 2025
The record high comes as investors reassess Micron’s positioning in the AI-driven memory market.
Via Stocktwits · December 24, 2025
TRC is looking to purchase 1.25 million shares of Netflix common stock at a price of $91 per share in cash.
Via Stocktwits · December 24, 2025
Pfizer Confirms Death Of Patient Enrolled In Hemophilia Drug Studystocktwits.com
Via Stocktwits · December 23, 2025
Why Did Cemtrex Stock Tumble Over 19% Today?stocktwits.com
Via Stocktwits · December 23, 2025
Is Salesforce The Loser In The AI Race? Dan Ives Says No — But Palantir Is Emerging As The Next Oraclestocktwits.com
Via Stocktwits · December 23, 2025
MannKind Stock Slips Despite FDA Clearing Pediatric Use Of Heart Failure Drug — What’s Spooking Investors?stocktwits.com
Via Stocktwits · December 23, 2025
Regulatory thaw, political backing, and late-stage data are propelling psychedelic drugmakers into the biotech spotlight — with Compass Pathways and Mind Medicine leading the charge.
Via Stocktwits · December 24, 2025
The drug was approved for use in adults and children aged two years and older.
Via Stocktwits · December 24, 2025
Agios Pharmaceuticals announced that the FDA approved its oral therapy for anemia in adults with alpha- or beta-thalassemia.
Via Stocktwits · December 24, 2025
The two companies will work together to make it easier for consumers to use Rokid glasses with Wearable Devices’ Mudra Link neural wristband for touch-free, wrist-based control.
Via Stocktwits · December 24, 2025
Retail investors are actively discussing recent clinical trials and the potential for a buyout or takeover.
Via Stocktwits · December 24, 2025
The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.
Via Stocktwits · December 24, 2025
According to data released by the U.S. Department of Labor on Wednesday, jobless claims fell by 10,000 to 214,000 in the week ended December 20.
Via Stocktwits · December 24, 2025
Hims & Hers has drawn scrutiny for selling compounded GLP-1 treatments – lower-cost, unapproved alternatives to blockbuster weight-loss drugs made by Eli Lilly and Novo Nordisk.
Via Stocktwits · December 24, 2025
Government backing, factory expansion, and global deals are turning eVTOL hype into real-world momentum.
Via Stocktwits · December 24, 2025
Crypto analyst Benjamin Cowen advised investors not to overvalue holiday price movement as Bitcoin enters Christmas Eve.
Via Stocktwits · December 24, 2025
The FDA decision on Narsoplimab, its treatment for post–stem cell and bone marrow transplant complications, is officially due on December 26.
Via Stocktwits · December 24, 2025
Meta has reportedly called the order ‘fundamentally flawed’, and said it plans to appeal.
Via Stocktwits · December 24, 2025
Repare stated that Gilead has agreed to acquire polymerase theta (Polθ) ATPase inhibitor, RP-3467, for a total consideration of $30 million.
Via Stocktwits · December 24, 2025
According to a Reuters report, Nvidia Corp.(NVDA) recently evaluated whether Intel’s 18A manufacturing process could be used to produce its own chips.
Via Stocktwits · December 24, 2025
He argued that sustained supply-side improvements could contain inflation, despite solid GDP growth.
Via Stocktwits · December 24, 2025
Robotaxi momentum is lifting Tesla stock, as Waymo still leads, China accelerates competition, and analysts see autonomous rides as a significant long-term driver of valuation for growth.
Via Stocktwits · December 24, 2025
OPEN’s stock is down about 40% from its mid-September peak.
Via Stocktwits · December 24, 2025
The New York Stock Exchange and the Nasdaq will be open for trading on Christmas Eve till 1 p.m. ET, with the NYSE staying open for options trading till 1:15 p.m. ET.
Via Stocktwits · December 24, 2025
The U.S. auto safety regulator has opened a defect petition into 179,071 Tesla Model 3 vehicles.
Via Stocktwits · December 24, 2025
The People's Bank of China advised accelerating Western Land-Sea New Corridor construction.
Via Stocktwits · December 24, 2025
Hayes sold nearly 1,900 ETH over the past week while accumulating three DeFi tokens.
Via Stocktwits · December 24, 2025
Nike has been trying to right its playbook, and for that, it has had consistent support from Cook, someone who has been around to see the company fall and pick itself up again.
Via Stocktwits · December 24, 2025
The automation and AI software provider will replace Synovus Financial Corp., and the update will take effect before markets open on Jan. 2, 2026.
Via Stocktwits · December 24, 2025
BP’s majority stake sale of its Castrol business to Stonepeak is expected to close by the end of 2026.
Via Stocktwits · December 24, 2025
Ramaco’s CEO said that, with $600 million-plus (before fees) in capital raises in the second half of 2025, the firm is well-positioned to pursue opportunities to unlock value and maximize shareholder returns.
Via Stocktwits · December 24, 2025
The strategist also pointed to strong consumer spending in the third quarter despite a cooling labor market.
Via Stocktwits · December 24, 2025
French drugmaker Sanofi agreed to acquire vaccine maker Dynavax in a $2.2 billion deal.
Via Stocktwits · December 24, 2025
Bitcoin price movement has relied on investor narratives, said Novogratz, and excitement may not return until Bitcoin breaks $100,000.
Via Stocktwits · December 24, 2025
“High salaries, no talent, really low ratings,” Trump says in his attack against late show hosts at CBS, ABC, and NBC.
Via Stocktwits · December 24, 2025
Weight-loss drugs, drug-pricing reforms, and legal challenges have reshaped the U.S. healthcare landscape in 2025.
Via Stocktwits · December 24, 2025
A 1,900% rally, Phase 3 wins, and takeover chatter around Eli Lilly have transformed Abivax from a risky clinical bet into a strategic asset with real optionality.
Via Stocktwits · December 24, 2025
Schiff reiterated his long-standing view that Bitcoin lacks intrinsic value and is vulnerable to prolonged declines.
Via Stocktwits · December 24, 2025
Chainalysis estimated $40.9 billion in losses from crypto scams in 2024 and expects the numbers to increase further in 2025.
Via Stocktwits · December 24, 2025
Markets are moving from a record-setting close into a thin, holiday-shortened Christmas Eve session.
Via Stocktwits · December 24, 2025
AST SpaceMobile’s shares have built on the momentum of its Bluebird launches as well as several deals with the likes of Verizon and the U.S. government.
Via Stocktwits · December 24, 2025
Bitcoin's decline below $88,000, year-end tax-loss, and recent sales of insider holdings have impacted Coinbase's stock.
Via Stocktwits · December 24, 2025
DJT’s total Bitcoin holdings previously stood at 11,542 BTC, valued at more than $1 billion, per Arkham data.
Via Stocktwits · December 24, 2025
Altcoins were down as long-side leverage saw pressure. Ethereum and Solana led the way in liquidations as the market turned cautious.
Via Stocktwits · December 23, 2025
Mining stocks posted modest after-hours gains despite broader weakness in crypto prices.
Via Stocktwits · December 23, 2025
Newman outlined eight predictions on Tuesday, spanning crypto, AI and IPOs.
Via Stocktwits · December 23, 2025
The insider purchase drew attention as investors weighed encouraging earnings against ongoing cost pressures and regional headwinds.
Via Stocktwits · December 23, 2025
Ford issued 150 recalls in the U.S. this year while GM issued 27 and Stellantis, 53.
Via Stocktwits · December 23, 2025
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Riskstocktwits.com
Via Stocktwits · December 23, 2025
The National Economic Council Director said the third-quarter GDP data signals that President Donald Trump’s trade agenda is working and that the AI productivity boom is reflected in the data.
Via Stocktwits · December 23, 2025
The new patent is part of VisionWave’s Apollo patent family, which focuses on real-time RF-based movement detection, imaging, and AI-driven analysis.
Via Stocktwits · December 23, 2025
Following the Trump administration's executive order issued last week to sharpen the focus of the U.S. space policy, Starfighters Space stated that it will advance its commercial and government mission activities.
Via Stocktwits · December 23, 2025
The company received approval from the PHMSA to proceed with its restart plan for the Las Flores Pipeline System in California.
Via Stocktwits · December 23, 2025
Spain’s order with Raytheon for four Patriot systems will include radars, launchers, command-and-control stations, and training equipment.
Via Stocktwits · December 23, 2025
Aduro Clean Technologies closed a US$20M public offering of 1.74M shares plus warrants to fund its Demonstration-Scale Plant, R&D, and working capital, using chemistry to convert low-value feedstocks into higher-value resources.
Via Stocktwits · December 23, 2025
ZenaTech has closed its acquisition of Vara 3D, expanding its Drone as a Service business into the fast-growing solar infrastructure market for faster site planning, inspections, and maintenance.
Via Stocktwits · December 23, 2025
The company announced that the FDA called for an additional Phase 3 trial of its schizophrenia treatment drug.
Via Stocktwits · December 23, 2025
Carson Group’s Ryan Detrick also dismissed concerns of a bear market amid a decline in volatility this month.
Via Stocktwits · December 23, 2025
